Expression of microRNA Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease.
Oliver Buchhave PedersenErik Lerkevang GrovePeter H NissenSanne Bøjet LarsenLeonardo PasalicSteen Dalby KristensenAnne-Mette HvasPublished in: Thrombosis and haemostasis (2023)
Among patients with CAD, adding miR-223-3p expression to traditional cardiovascular risk factors may improve prediction of cardiovascular events, particularly ST. Clinical trials confirming these findings are warranted.
Keyphrases
- cardiovascular events
- coronary artery disease
- cardiovascular risk factors
- cardiovascular disease
- poor prognosis
- clinical trial
- percutaneous coronary intervention
- coronary artery bypass grafting
- metabolic syndrome
- binding protein
- long non coding rna
- aortic stenosis
- randomized controlled trial
- heart failure
- open label
- study protocol
- aortic valve
- left ventricular